NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Kemin Industries, Inc.
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kemin Launches Powerful New Xylanase Enzyme - KEMZYME® eXtend - While numerous experts have been focusing their research on a better understanding of the non-starch polysaccharide (NSP) fraction of wheat and the effect of enzymes, there were still gaps in the scientific knowledge and practical applications - Kemin.com
Kemin Launches Powerful New Xylanase Enzyme - KEMZYME® eXtend

 

NewswireToday - /newswire/ - Herentals, Belgium, 2015/03/19 - While numerous experts have been focusing their research on a better understanding of the non-starch polysaccharide (NSP) fraction of wheat and the effect of enzymes, there were still gaps in the scientific knowledge and practical applications - Kemin.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Therefore Kemin sponsored the Ph.D. study: “Interactions between non-starch polysaccharides from wheat and feed enzymes - effect on digestion in broilers" in order to further elucidate this important industry topic. The study’s thesis was successfully defended by Kemin Industries’ senior research associate in Europe and Ph.D. student, Natasja Smeets on March 6th at the Catholic University of Leuven.

The Ph.D. thesis determined the variability range in the chemical NSP composition between different wheat batches used across Europe. The data indicated an enormous variation between wheat grains. According to the research, the level of soluble NSP can range between 0.8 and 1.8%, whereas the level of insoluble NSP was shown to vary between 5.8% and 9.6%.

In a second step of the study, Smeets studied the impact of these variations in NSP levels on the nutrient digestibility of broilers. The last step of the research was designed to gain more insights on the interaction between the NSP fraction and feed enzymes.

A better understanding of the xylanase requirements and mode of action for optimal performance was an important outcome of this study. As a result the Kemin research team developed KEMZYME® eXtend, a premium xylanase extended with an activated carrier suitable for all poultry species.

“This Ph.D. study confirms the company’s obligation to better understand the challenges of NSP fractions caused in animal nutrition,” said Filip Nuyens, research and development director of the animal nutrition and health division in Europe. “This is just a portion of the research we do globally to demonstrate our commitment to delivering the best nutritional enzyme solutions in the industry.”

KEMZYME eXtend uses a unique xylanase that has several distinctive features. In addition to the traditional xylanase enzyme effect which breaks down the soluble xylans in order to reduce the viscosity of digesta, KEMZYME eXtend also releases additional nutrients such as starch and proteins by breaking open the aleurone and endosperm cell walls. Consequently the product contains both energy and crude protein values making it an interesting matrix value used in re-formulations. KEMZYME eXtend is also pellet stable up to up to 95°C.

Kemin provides unique solutions to enhance the utilization of today's complex feed with KEMZYME.
As feed formulations vary in different parts of the world, KEMZYME products are diverse and are designed to target these regional needs. This makes KEMZYME different than other enzyme products where one product needs to fit every situation in all parts of the world. KEMZYME® Plus is the ideal solution for complex substrates which require multiple enzyme activities for a complete solution, whereas KEMZYME® eXtend targets the single xylanase applications.

For more information on the benefits of KEMZYME eXtend which is available in European, Middle Eastern and African regions, or any of the KEMZYME solutions, contact your Kemin representative or Tin Marien at tin.marien[.]kemin.com or 32 14 28 62 60.

Kemin Inspired Molecular Solutions™
Kemin (kemin.com) provides “inspired molecular solutions” specifically developed to provide nutrition and health benefits for humans and animals. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where approximately 500 specialty ingredients are made for the global feed and food industries as well as the health, nutrition and beauty markets. A privately held, family-owned and operated company, Kemin has nearly 2,000 employees and operates in more than 90 countries with manufacturing facilities in Belgium, Brazil, China, India, Italy, Singapore, South Africa and the United States.

™® Trademarks of Kemin Industries, Inc.
Certain statements may not be applicable in all geographical regions. Product labeling and associated claims may differ based upon government requirements.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Kemin Industries, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kemin Launches Powerful New Xylanase Enzyme - KEMZYME® eXtend

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Tin Marien - Kemin.com 
+32 14 28 62 60 tin.marien[.]kemin.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kemin Industries, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kemin Industries, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

PharmaEssentia Selects Veeva Data Cloud to Support Launch of Novel Therapy for Rare, Chronic Blood Cancers
Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050 - A Novel Individualized Neoantigen Cancer Vaccine
DSM Plans New Production Site for Bovaer® in Dalry, Scotland
Celltrion Pharm Selects TrackWise QMS for Scalability and Data Integrity
Ipsen Adds Another Program into its Pre-clinical R&D Oncology Pipeline through An Exclusive Worldwide Collaboration with Accent Therapeutics
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  RightITnow, Inc.





 
  ©2022 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)